top of page
Bob Enck 1200px.jpg

Recent News

Monday, February 5th 2024

As part of a planned transition aimed at strengthening our leadership with a focus  on robust commercial growth in the Diagnostics and Sample Preparation industries, we are pleased to announce the appointment of Bob Enck, current Chairman and President, as CEO. 


Recent News

Thurs, December 21st 2023

ProtonDx’s Regulatory Affairs Director, Dr Kasia Szostak-Lipowicz, was invited to the UN Panel on Transformative Digital Diagnostic Technologies, where she discussed how ProtonDx’s work can help bridge healthcare gaps in Africa.

Screen Shot 2023-07-21 at 1.40.56 PM.png

Recent News

Thurs, November 2nd 2023

POCT-for-Scot Ltd. completed an evaluation of ProtonDx's multi-pathogen Dragonfly Respiratory diagnostic device. The study delves into the feasibility of using Dragonfly in Point-of-Care settings and provides insights into adoption by POC clinics! 

Jesus Rodriguez Manzano-475_edited.jpg

Recent News

Thurs, October 19th 2023

Dr Rodriguez Manzano's promotion to Associate Professor in the Department of Infectious Disease at Imperial College London showcases his dedication to advancing the field of Molecular Diagnostics, with a particular focus on addressing infections and antimicrobial resistance (AMR).


Recent News

Tue, September 26th 2023

ProtonDx's Dragonfly Respiratory Panel, a portable, accurate, and rapid diagnostic device, played a pivotal role in maintaining the health and performance of UK team members throughout the Tour de France 2023.

Recent News

Tue, March 28th 2023

ProtonDx's proprietary rapid multipathogen test was a key diagnostic element used to test the Finnish cross-country skiers in The FIS Nordic World Ski Championships in Planica, Slovenia, in February - March 2023.

bottom of page